Exelixis, Cereplast gain; drug indexes split
August 26, 2010 at 10:49 AM EDT
Shares of Exelixis gain ground a day after regulatory filings revealed that two of its top execs made substantial purchases of the biotech company's stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.